首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Ovarian response to stimulation for fertility preservation in women with malignant disease: A systematic review and meta-analysis
【24h】

Ovarian response to stimulation for fertility preservation in women with malignant disease: A systematic review and meta-analysis

机译:卵巢对刺激以维持恶性疾病妇女的生育能力的反应:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the current available data regarding ovarian performance of patients diagnosed with malignant disease undergoing controlled ovarian hyperstimulation (COH) for fertility preservation, before radio/chemotherapy, compared with age-matched, healthy patients undergoing COH for in vitro fertilization/intracytoplasmic sperm injection (IVF-ICSI). Design: Meta-analysis of the data available from a systematic review of the literature. Setting: Academic centers of infertility and IVF. Patient(s): Patients with malignant disease, before radio/chemotherapy, undergoing COH for fertility preservation within comparative studies with healthy, age-matched controls. Intervention(s): None. Main Outcome Measure(s): Peak estradiol levels on day of human chorionic gonadotropin administration, number of oocytes retrieved, fertilization rate, incidence of low ovarian response, and cycle cancellation. Result(s): Only seven retrospective, case-controlled studies were found to match our objective. Overall, the results of the meta-analysis indicate that the number of retrieved oocytes rate was statistically significantly lower compared with age-matched healthy IVF patients. The incidence of poor ovarian performance and risk of cycle cancellation as well as the calculated number of two pronuclei zygotes achieved among patients with cancer were comparable with their age-matched controls. Conclusion(s): Women with malignant disease should expect a lower number of oocytes retrieved after COH for fertility preservation, compared with healthy, age-matched patients. Presently, there is paucity of evidence to assess the effect of a specific malignant disease on ovarian response to COH before IVF for fertility preservation. Multicentric studies should be conducted to resolve these important issues.
机译:目的:评估在放疗/化疗前接受控制性卵巢过度刺激(COH)保留生育力的恶性疾病患者的卵巢性能的现有数据,与进行体外受精/胞浆内精子的年龄匹配的健康患者相比,对这些患者的卵巢性能进行评估注射(IVF-ICSI)。设计:对文献进行系统回顾获得的数据的荟萃分析。地点:不孕和IVF的学术中心。患者:在放疗/化学疗法之前,患有恶性疾病的患者在健康年龄匹配的对照研究中接受了COH以保留生育力。干预措施:无。主要观察指标:施用绒毛膜促性腺激素当天的雌二醇峰值水平,回收的卵母细胞数,受精率,低卵巢反应发生率和周期取消。结果:仅发现七项回顾性病例对照研究符合我们的目标。总体而言,荟萃分析的结果表明,与年龄相匹配的健康IVF患者相比,卵母细胞的回收率在统计学上显着降低。卵巢恶性肿瘤的发生率和周期取消的风险,以及在癌症患者中达到的两种原核合子的计算数量与年龄匹配的对照组相当。结论:与健康的,年龄匹配的患者相比,恶性疾病的妇女应期望在COH后用于保留生育能力的卵母细胞数量减少。目前,尚无足够的证据来评估特定的恶性疾病对IVF保留生育前卵巢对COH反应的影响。应该进行多中心研究来解决这些重要问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号